Chemed ( (CHE) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Chemed’s stock is experiencing downward pressure primarily due to BofA’s decision to lower the price target, citing concerns over a negative policy and reimbursement environment. Despite the company’s strong hospital fundamentals and a positive outlook fueled by favorable Medicare rates and strategic share repurchases, insider selling has increased, which may be affecting investor confidence. Some analysts have upgraded their ratings, but the overall sentiment remains cautious.
More about Chemed
YTD Price Performance: -12.38%
Average Trading Volume: 182,430
Technical Sentiment Signal: Sell
Current Market Cap: $6.76B
For further insights into CHE stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.